5 min listen
Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab.
Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab.
ratings:
Length:
5 minutes
Released:
Sep 7, 2023
Format:
Podcast episode
Description
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses research that assesses the safety of endovascular treatment post-stroke for people with intracranial tumors, the AANEM guideline on IVIG use for neuromuscular disorders, and the latest data on donanemab.
Released:
Sep 7, 2023
Format:
Podcast episode
Titles in the series (99)
June 4 Issue Introduction: Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 4, 2020 issue. by Neurology Today in 5